These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12852948)

  • 21. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
    Hasegawa M; Nishigaki N; Washio Y; Kano K; Harris PA; Sato H; Mori I; West RI; Shibahara M; Toyoda H; Wang L; Nolte RT; Veal JM; Cheung M
    J Med Chem; 2007 Sep; 50(18):4453-70. PubMed ID: 17676829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.
    Hammach A; Barbosa A; Gaenzler FC; Fadra T; Goldberg D; Hao MH; Kroe RR; Liu P; Qian KC; Ralph M; Sarko C; Soleymanzadeh F; Moss N
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6316-20. PubMed ID: 17010605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).
    Brink M; Dahlén A; Olsson T; Polla M; Svensson T
    Bioorg Med Chem; 2014 Apr; 22(7):2261-8. PubMed ID: 24588961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding.
    Fraley ME; Arrington KL; Buser CA; Ciecko PA; Coll KE; Fernandes C; Hartman GD; Hoffman WF; Lynch JJ; McFall RC; Rickert K; Singh R; Smith S; Thomas KA; Wong BK
    Bioorg Med Chem Lett; 2004 Jan; 14(2):351-5. PubMed ID: 14698157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors.
    Zhao Z; Arnaiz DO; Griedel B; Sakata S; Dallas JL; Whitlow M; Trinh L; Post J; Liang A; Morrissey MM; Shaw KJ
    Bioorg Med Chem Lett; 2000 May; 10(9):963-6. PubMed ID: 10853669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.
    Sammond DM; Nailor KE; Veal JM; Nolte RT; Wang L; Knick VB; Rudolph SK; Truesdale AT; Nartey EN; Stafford JA; Kumar R; Cheung M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3519-23. PubMed ID: 15990302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors.
    Hamblett CL; Methot JL; Mampreian DM; Sloman DL; Stanton MG; Kral AM; Fleming JC; Cruz JC; Chenard M; Ozerova N; Hitz AM; Wang H; Deshmukh SV; Nazef N; Harsch A; Hughes B; Dahlberg WK; Szewczak AA; Middleton RE; Mosley RT; Secrist JP; Miller TA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5300-9. PubMed ID: 17761416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluation.
    Hughes TV; Emanuel SL; Beck AK; Wetter SK; Connolly PJ; Karnachi P; Reuman M; Seraj J; Fuentes-Pesquera AR; Gruninger RH; Middleton SA; Lin R; Davis JM; Moffat DF
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3266-70. PubMed ID: 17481894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors.
    He W; Hanney B; Myers MR; Condon S; Becker MR; Spada AP; Burns C; Brown K; Colussi D; Chu V
    Bioorg Med Chem Lett; 2002 Mar; 12(6):919-22. PubMed ID: 11958994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitors.
    Manku S; Allan M; Nguyen N; Ajamian A; Rodrigue J; Therrien E; Wang J; Guo T; Rahil J; Petschner AJ; Nicolescu A; Lefebvre S; Li Z; Fournel M; Besterman JM; Déziel R; Wahhab A
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1866-70. PubMed ID: 19272776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors.
    Akritopoulou-Zanze I; Darczak D; Sarris K; Phelan KM; Huth JR; Song D; Johnson EF; Jia Y; Djuric SW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):96-9. PubMed ID: 16216502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src kinase inhibitors.
    Berger D; Dutia M; Powell D; Wu B; Wissner A; DeMorin F; Weber J; Boschelli F
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2761-5. PubMed ID: 12217371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
    Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk).
    Moriarty KJ; Takahashi H; Pullen SS; Khine HH; Sallati RH; Raymond EL; Woska JR; Jeanfavre DD; Roth GP; Winters MP; Qiao L; Ryan D; DesJarlais R; Robinson D; Wilson M; Bobko M; Cook BN; Lo HY; Nemoto PA; Kashem MA; Wolak JP; White A; Magolda RL; Tomczuk B
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5545-9. PubMed ID: 18819799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient syntheses of KDR kinase inhibitors using a Pd-catalyzed tandem C-N/Suzuki coupling as the key step.
    Fang YQ; Karisch R; Lautens M
    J Org Chem; 2007 Feb; 72(4):1341-6. PubMed ID: 17253753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase.
    Beshore DC; Bell IM; Dinsmore CJ; Homnick CF; Culberson JC; Robinson RG; Fernandes C; Walsh ES; Abrams MT; Bhimnathwala HG; Davide JP; Ellis-Hutchings MS; Huber HA; Koblan KS; Buser CA; Kohl NE; Lobell RB; Chen IW; McLoughlin DA; Olah TV; Graham SL; Hartman GD; Williams TM
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1817-21. PubMed ID: 11459639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L; Wu TT; Wang Z; Xue JY; Xu YG
    Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
    Guo Q; Chandrasekhar J; Ihle D; Wustrow DJ; Chenard BL; Krause JE; Hutchison A; Alderman D; Cheng C; Cortright D; Broom D; Kershaw MT; Simmermacher-Mayer J; Peng Y; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5027-31. PubMed ID: 18752949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases.
    Sun L; Tran N; Liang C; Tang F; Rice A; Schreck R; Waltz K; Shawver LK; McMahon G; Tang C
    J Med Chem; 1999 Dec; 42(25):5120-30. PubMed ID: 10602697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.